Work

Pimavanserin: A Novel Drug Approved to Treat Parkinson's Disease Psychosis.

Year: 2018

Type: article

Abstract: : Evidence suggests pimavanserin attenuates PDP symptoms with few adverse effects and little risk of worsening motor function. With limited treatment options for PDP, pimavanserin represents an important therapeutic innovation.

Source: PubMed Central

Authors: Amanda K Kitten, Sarah A Hallowell, Stephen R Saklad, Kirk E Evoy

Institution: The University of Texas at Austin

Language: English

Topic: Parkinson's Disease Mechanisms and Treatments

Subfield: Clinical Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W2903176273

FWCI: 2.676

Cites: 28

Cited by: 39

Related to: 10